Transcriptome profiling of spinal muscular atrophy motor neurons derived from mouse embryonic stem cells

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Maeda, Miho ^a,b   Harris, Ashlee W ^a   Kingham, Brewster F ^b   Lumpkin, Casey J ^a,b   Opdenaker, Lynn M ^b   Mccahan, Suzanne M ^a,c   Wang, Wenlan ^a,b   Butchbach, Matthew E R ^a,b,c  

^a NEMOURS ALFRED I DUPONT HOSPITAL FOR CHILDREN   (United States)

^b UNIVERSITY OF DELAWARE   (United States)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SURVIVAL MOTOR NEURON PROTEIN 2; TRANSCRIPTOME; SMN2 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CRABP1 GENE; CRABP2 GENE; DOWN REGULATION; EMBRYO; EMBRYONIC STEM CELL; FEMALE; GENE; GENE DOSAGE; GENE EXPRESSION; IN VITRO STUDY; MOTONEURON; MOUSE; NERVE CELL DIFFERENTIATION; NKX2.2 GENE; NONHUMAN; PLURIPOTENT STEM CELL; RNA SEQUENCE; RNA TRANSCRIPTION; SMN2 GENE; SPINAL CORD; SPINAL MUSCULAR ATROPHY; UPREGULATION; ANIMAL; BIOLOGICAL MODEL; CASE CONTROL STUDY; CELL CULTURE; CYTOLOGY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENETICS; HIGH THROUGHPUT SEQUENCING; PATHOLOGY; PROCEDURES;

ANIMALS; CASE-CONTROL STUDIES; CELLS, CULTURED; EMBRYONIC STEM CELLS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORKS; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; MICE; MODELS, BIOLOGICAL; MOTOR NEURONS; MUSCULAR ATROPHY, SPINAL; SURVIVAL OF MOTOR NEURON 2 PROTEIN;

EID: 84906993523     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0106818     Document Type: Article

References (103)

1. Crawford TO, Pardo CA (1996) The neurobiology of childhood spinal muscular atrophy. Neurobiol Dis 3: 97-110.
2. Cuscó I, Barceló MJ, Soler C, Parra J, Baiget M, et al. (2002) Prenatal diagnosis for risk of spinal muscular atrophy. Br J Obstet Gynaecol 109: 1244-1249.
3. Pearn J (1978) Incidence, prevalence and gene frequency studies of chronic childhood spinal muscular atrophy. J Med Genet 15: 409-413.
4. Ben-Shachar S, Orr-Urtreger A, Bardugo E, Shomrat R, Yaron Y (2011) Large-scale population screening for spinal muscular atrophy: clinical implications. Genet Med 13: 110-114.
5. Sugarman EA, Nagan N, Zhu H, Akmaev VR, Zhou Z, et al. (2012) Pan-ethnic carrier screening and prenatal diagnosis for spinal muscular atrophy: clinical laboratory analysis of .72400 specimens. Eur J Hum Genet 20: 27-32.
6. Su YN, Hung CC, Lin SY, Chen FY, Chern JPS, et al. (2011) Carrier screening for spinal muscular atrophy (SMA) in 107, 611 pregnant women during the period 2005-2009: A prospective population-based cohort study. PLoS ONE 6: e17067.
7. Lyahyai J, Sbiti A, Barkat A, Ratbi I, Sefiani A (2012) Spinal muscular atrophy carrier frequency and estimated prevalence of the disease in Moroccan newborns. Genet Test Mol Biomarkers 16: 215-218.
8. Lefebvre S, Bürglen L, Reboullet S, Clermont O, Burlet P, et al. (1995) Identification and characterization of a spinal muscular atrophy-determining gene. Cell 80: 155-165.
9. Lorson CL, Hahnen E, Androphy EJ, Wirth B (1999) A single nucleotide in the SMN gene regulates splicing an is responsible for spinal muscular atrophy. Proc Natl Acad Sci U S A 96: 6307-6311.
10. Monani UR, Lorson CL, Parsons DW, Prior TW, Androphy EJ, et al. (1999) A single nucleotide difference that alters splicing patterns distinguishes the SMA gene SMN1 from the copy gene SMN2. Hum Mol Genet 8: 1177-1183.
11. Lorson CL and Androphy EJ (2000) An exonic enhancer is required for inclusion of an essential exon in the SMA-determining gene SMN. Hum Mol Genet 9: 259-265.
12. Cho S and Dreyfuss G (2010) A degron created by SMN2 exon 7 skipping is a principal contributor to spinal muscular atrophy severity. Genes Dev 24: 438- 442.
13. Coovert DD, Le TT, McAndrew PE, Strasswimmer J, Crawford TO, et al. (1997) The survival motor neuron protein in spinal muscular atrophy. Hum Mol Genet 6: 1205-1214.
14. Lefebvre S, Burlet P, Liu Q, Bertrandy S, Clermont O, et al. (1997) Correlation between severity and SMN protein level in spinal muscular atrophy. Nat Genet 16: 265-269.
15. McAndrew PE, Parsons DW, Simard LR, Rochette C, Ray PN, et al. (1997) Identification of proximal spinal muscular atrophy carriers and patients by analysis of SMNT and SMNC gene copy number. Am J Hum Genet 60: 1411- 1422.
16. Prior TW, Swoboda KJ, Scott HD, Hejmanowski AQ (2005) Homozygous SMN1 deletions in unaffected family members and modification of the phenotype by SMN2. Am J Med Genet 130A: 307-310.
17. Wirth B, Brichta L, Schrank B, Lochmü ller H, Blick S, et al. (2006) Mildly affected patients with spinal muscular atrophy are partially protected by an increased SMN2 copy number. Hum Genet 119: 422-428.
18. Swoboda KJ, Prior TW, Scott CB, McNaught TP, Wride MC, et al. (2005) Natural history of denervation in SMA: relation to age, SMN2 copy number and function. Ann Neurol 57: 704-712.
19. Elsheikh B, Prior T, Zhang X, Miller R, Kolb SJ, et al. An analysis of disease severity based on SMN2 copy number in adults with spinal muscular atrophy. Muscle Nerve 40: 652-656.
20. Tiziano FD, Bertini E, Messina S, Angelozzi C, Pane M, et al. (2007) The Hammersmith functional score correlates with the SMN2 copy number: A multicentric study. Neuromuscul Disord 17: 400-403.
21. Burghes AHM and Beattie CE (2009) Spinal muscular atrophy: why do low levels of survival motor neuron protein make motor neurons sick? Nat Rev Neurosci 10: 597-609.
22. Gabanella F, Carissimi C, Usiello A, Pellizzoni L (2005) The activity of the spinal muscular atrophy protein is regulated during development and cellular differentiation. Hum Mol Genet 14: 3629-3642.
23. Winkler C, Eggert C, Gradl D, Meister G, Giegerich M, et al. (2005) Reduced U snRNP assembly causes motor axon degeneration in an animal model for spinal muscular atrophy. Genes Dev 19: 2320-2330.
24. Wan L, Battle DJ, Yong J, Gubitz AK, Kolb SJ, et al. (2005) The survival of motor neurons protein determines the capacity for snRNP assembly: biochemical deficiency in spinal muscular atrophy. Mol Cell Biol 25: 5543- 5551.
25. Pagliardini S, Giavizzi A, Setola V, Lizier C, Di Luca M, et al. (2000) Subcellular localization and axonal transport of the survival motor neuron (SMN) protein in developing rat spinal cord. Hum Mol Genet 9: 47-56.
26. McWhorter ML, Monani UR, Burghes AHM, Beattie CE (2003) Knockdown of the survival motor neuron (Smn) protein in zebrafish causes defects in motor axon outgrowth and pathfinding. J Cell Biol 162: 919-931.
27. Carrel TL, McWhorter ML, Workman E, Zhang H, Wolstencroft EC, et al. (2006) Survival motor neuron function in motor axons is independent of functions required for small nuclear ribonucleoprotein biogenesis. J Neurosci 26: 11014-11022.
28. Zhang H, Xing L, Rossoll W, Wichterle H, Singer RH, et al. (2006) Multiprotein complexes of the survival of motor neuron protein SMN with gemins traffic to neuronal processes and growth cones of motor neurons. J Neurosci 26: 8622-8632.
29. Mourelatos Z, Abel L, Yong J, Kataoka N, Dreyfuss G (2001) SMN interacts with a novel family of hnRNP and spliceosomal proteins. EMBO J 20: 5443- 5452.
30. Rossoll W, Jablonka S, Andreassi C, Kröning AK, Karle K, et al. (2003) Smn, the spinal muscular atrophy-determining gene product, modulates axon growth and localization of b-actin mRNA in growth cones of motoneurons. J Cell Biol 163: 801-812.
31. Bassell GJ, Zhang H, Byrd AL, Femino AM, Singer RH, et al. (1998) Sorting of b-actin mRNA and protein to neurites and growth cones in culture. J Neurosci 18: 251-265.
32. Cheever TR, Olson EA, Ervasti JM (2011) Axon regeneration and neuronal function are preserved in motor neurons lacking b-actin in vivo. PLoS ONE 6: e17768.
33. Schrank B, Götz R, Gunnersen JM, Ure JM, Toyka KV, et al. (1997) Inactivation of the survival motor neuron gene, a candidate gene for human spinal muscular atrophy, leads to massive cell death in early mouse embryos. Proc Natl Acad Sci U S A 94: 9920-9925.
34. Monani UR, Sendtner M, Coovert DD, Parsons DW, Andreassi C, et al. (2000) The human centromeric survival motor neuron gene (SMN2) rescues embryonic lethality in Smn2/2 mice and results in a mouse with spinal muscular atrophy. Hum Mol Genet 9: 333-339.
35. Hsieh-Li HM, Chang JG, Jong YJ, Wu MH, Wang NM, et al. (2000) A mouse model for spinal muscular atrophy. Nat Genet 24: 66-70.
36. Michaud M, Arnoux T, Bielli S, Durand E, Rotrou Y, et al. (2010) Neuromuscular defects and breathing disorders in a new mouse model of spinal muscular atrophy. Neurobiol Dis 38: 125-135.
37. Wichterle H, Lieberam I, Porter JA, Jessell TM (2002) Directed differentiation of embryonic stem cells into motor neurons. Cell 110: 385-397.
38. Miles GB, Yohn DC, Wichterle H, Jessell TM, Rafuse VF, et al. (2004) Functional properties of motoneurons derived from mouse embryonic stem cells. J Neurosci 24: 7848-7858.
39. Makhortova NR, Hayhurst M, Cerqueira A, Sinor-Anderson AD, Zhao WN, et al. (2011) A screen for regulators of survival of motor neuron protein levels. Nat Chem Biol 7: 544-552.
40. Anderson KN, Baban D, Oliver PL, Potter A, Davies KE (2004) Expression profiling in spinal muscular atrophy reveals an RNA binding protein deficit. Neuromuscul Disord 14: 711-722.
41. Zhang Z, Lotti F, Dittmar K, Younis I, Wan L, et al. (2008) SMN deficiency causes tissue-specific perturbations in the repertoire of snRNAs and widespread defects in splicing. Cell 133: 585-600.
42. Murray LM, Lee S, Bäumer D, Parson SH, Talbot K, et al. (2010) Presymptomatic development of lower motor neuron connectivity in a mouse model of severe spinal muscular atrophy. Hum Mol Genet 19: 420-433.
43. Sultan M, Schulz MH, Richard H, Magen A, Klingenhoff A, et al. (2008) A global view of gene activity and alternative splicing by deep sequencing of the human transcriptome. Science 321: 956-960.
44. Wang Z, Gerstein M, Snyder M (2009) RNA-Seq: A revolutionary tool for transcriptosomics. Nat Rev Genet 10: 57-63.
45. McGovern VL, Gavrilina TO, Beattie CE, Burghes AHM (2008) Embryonic motor axon development in the severe SMA mouse. Hum Mol Genet 17: 2900-2909.
46. Wu CY, Whye D, Glazewski L, Choe L, Kerr D, et al. (2011) Proteomic assessment of a cell model of spinal muscular atrophy. BMC Neurosci 12: 25.
47. Wu CY, Whye D, Mason RW, Wang W (2012) Efficient differentation of mouse embryonic stem cells into motor neurons. J Vis Exp 3813.
48. Butchbach MER, Edwards JD, Schussler KR, Burghes AHM (2007) A novel method for oral delivery of compounds to the neonatal SMND7 model of spinal muscular atrophy. J Neurosci Methods 161: 285-290.
49. Barrett T, Wilhite SE, Ledoux P, Evangelista C, Kim IF, et al. (2013) NCBI GEO: Archive for functional genomics data sets-update. Nucleic Acids Res 41: D991-D995.
50. Martin M (2011) Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBNet Journal 17: 10-12.
51. Trapnell C, Pachter L, Salzberg SL (2009) TopHat: discovering splice junctions with RNA-Seq. Bioinformatics 25: 1105-1111.
52. Trapnell C, Williams BA, Pertea G, Mortazavi A, Kwan G, et al. (2010) Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat Biotechnol 28: 511-515.
53. Trapnell C, Roberts A, Goff L, Pertea G, Kim D, et al. (2012) Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks. Nat Protoc 7: 562-578.
54. Juknat A, Pietr M, Kozela E, Rimmerman N, Levy R, et al. (2013) Microarray and pathway analysis reveal distinct mechanisms underlying cannabinoidmediated modulation of LPS-induced activation of BV-2 microglial cells. PLoS ONE 8: e61462.
55. Krämer A, Green J, Pollard Jr J, Tugendreich S (2014) Causal analysis approaches in Ingenuity Pathway Analysis. Bioinformatics 30: 523-530.
56. Schmittgen TD and Livak KJ (2008) Analyzing real-time PCR data by the comparative CT method. Nat Protoc 3: 1101-1108.
57. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, et al. (2002) Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3: research0034.1- research0034.11.
58. Arber S, Han B, Mendelsohn M, Smith M, Jessell TM, et al. (1999) Requirement for the homeobox gene Hb9 in the consolidation of motor neuron identity. Neuron 23: 659-674.
59. Pfaff SL, Mendelsohn M, Stewart CL, Edlund T, Jessell TM (1996) Requirement for LIM homeobox gene Isl1 in motor neuron generation reveals a motor neuron-dependent step in interneuron differentiation. Cell 84: 309-320.
60. Fang Z and Cui X (2011) Design and validation issues in RNA-seq experiments. Brief Bioinform 12: 280-287.
61. Jablonka S, Schrank B, Kralewski M, Rossoll W, Sendtner M (2000) Reduced survival motor neuron (Smn) gene dose in mice leads to motor neuron degeneration: An animal model for spinal muscular atrophy type III. Hum Mol Genet 9: 341-346.
62. Garcia EL, Lu Z, Meers MP, Praveen K, Matera AG (2013) Developmental arrest of Drosophila survival motor neuron (Smn) mutants accounts for differences in expression of minor intron-containing genes. RNA 19: 1510- 1516.
63. See K, Yadav P, Giegerich M, Cheong PS, Graf M, et al. (2014) SMN deficiency alters Nrxn2 expression and splicing in zebrafish and mouse models of spinal muscular atrophy. Hum Mol Genet 23: 1754-1770.
64. Zhang Z, Pinto AM, Wan L, Wang W, Berg MG, et al. (2013) Dysregulation of synaptogenesis genes antecedes motor neuron pathology in spinal muscular atrophy. Proc Natl Acad Sci U S A 110: 19348-19353.
65. Park GH, Maneo-Hikichi Y, Awano T, Landmesser LT, Monani UR (2010) Reduced survival of motor neuron (SMN) protein in motor neuronal progenitors functions cell autonomously to cause spinal muscular atrophy in model mice expressing the human centromeric (SMN2) gene. J Neurosci 30: 12005-12019.
66. Martinez TL, Kong L, Wang X, Osborne MA, Crowder ME, et al. (2012) Survival motor neuron protein in motor neurons determines synaptic integrity in spinal muscular atrophy. J Neurosci 32: 8703-8715.
67. Gogliotti RG, Quinlan KA, Barlow CB, Heier CR, Heckman CJ, et al. (2012) Motor neuron rescue in spinal muscular atrophy mice demonstrates that sensory-motor defects are a consequence, not a cause, of motor neuron dysfunction. J Neurosci 32: 3818-3829.
68. Gavrilina TO, McGovern VL, Workman E, Crawford TO, Gogliotti RG, et al. (2008) Neuronal SMN expression corrects spinal muscular atrophy in severe SMA mice while muscle specific SMN expression has no phenotypic effect. Hum Mol Genet 17: 1063-1075.
69. Hua Y, Sahashi K, Rigo F, Hung G, Horev G, et al. (2011) Peripheral SMN restoration is essential for long-term rescue of a severe spinal muscular atrophy mouse model. Nature 478: 123-126.
70. Passini MA, Bu J, Roskelley EM, Richards AM, Sardi SP, et al. (2010) CNStargeted gene therapy improves survival and motor function in a mouse model of spinal muscular atrophy. J Clin Invest 120: 1253-1264.
71. Foust KD, Wang X, McGovern VL, Braun L, Bevan AK, et al. (2010) Rescue of the spinal muscular atrophy phenotype in a mouse model by early postnatal delivery of SMN. Nat Biotechnol 28: 271-274.
72. Butchbach MER, Singh J, Orsteindóttir M, Saieva L, Slominski E, et al. (2010) Effects of 2, 4-diaminoquinazoline derivatives on SMN expression and phenotype in a mouse model for spinal muscular atrophy. Hum Mol Genet 19: 454-467.
73. Van Meerbeke JP, Gibbs RM, Plasterer HL, Miao W, Feng Z, et al. (2013) The DcpS inhibitor RG3039 improves motor function in SMA mice. Hum Mol Genet 22: 4074-4083.
74. Gogliotti RG, Cardona H, Singh J, Bail S, Emery C, et al. (2013) The DcpS inhibitor RG3039 improves survival, function and motor unit pathologies in two SMA mouse models. Hum Mol Genet 22: 4084-4101.
75. Azzouz M, Le T, Ralph GS, Walmsley L, Monani UR, et al. (2004) Lentivector-mediated SMN replacement in a mouse model of spinal muscular atrophy. J Clin Invest 114: 1726-1731.
76. Dominguez E, Marais T, Chatauret N, Benkhelifa-Ziyyat S, Duque S, et al. (2011) Intravenous scAAV9 delivery of a codon-optimized SMN1 sequence rescues SMA mice. Hum Mol Genet 20: 681-693.
77. Valori CF, Ning K, Wyles M, Mead RJ, Grierson AJ, et al. (2010) Systemic delivery of scAAV9 expressin SMN prolongs survival in a model of spinal muscular atrophy. Sci Transl Med 2: 35ra42.
78. Boyer LA, Lee TI, Cole MF, Johnstone SE, Levine SS, et al. (2005) Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 122: 947-956.
79. Redmond LC, Dumur CI, Archer KJ, Grayson DR, Haar JL, et al. (2011) Krüppel-like factor 2 regulated gene expression in mouse embryonic yolk sac erythroid cells. Blood Cells Mol Dis 47: 1-11.
80. Lim LS, Loh YH, Zhang W, Li Y, Chen X, et al. (2007) Zic3 is required for maintenance of pluripotency in embryonic stem cells. Mol Biol Cell 18: 1348- 1358.
81. Zhang W, Walker E, Tamplin OJ, Rossant J, Stanford WL, et al. (2006) Zfp206 regulates ES cell gene expression and differentiation. Nucleic Acids Res 34: 4780-4790.
82. Kim SK, Suh MR, Yoon HS, Lee JB, Oh SK, et al. (2005) Identification of developmental pluripotency associated 5 expression in human pluripotent stem cells. Stem Cells (Dayt) 23: 458-462.
83. Masui S, Ohtsuka S, Yagi R, Takahashi K, Ko MSH, et al. (2008) Rex1/Zfp42 is dispensable for pluripotency in mouse ES cells. BMC Dev Biol 8: 45.
84. Papetti M and Aughenlicht LH (2010) MYBL2, a link between proliferation and differentiation in maturing colon epithelial cells. J Cell Physiol 226: 785- 791.
85. Boyne LJ, Fischer I, Shea TB (1996) Role of vimentin in early stages of neuritogenesis in cultured hippocampal neurons. Int J Dev Neurosci 14: 739- 748.
86. Briscoe J, Sussel L, Serup P, Hartigan-O'Connor D, Jessell TM, et al. (1999) Homeobox gene Nkx2.2 and specification of neuronal identity by graded Sonic hedgehog signaling. Nature 398: 622-627.
87. Pierfelice T, Alberi L, Gaiano N (2011) Notch in the vertebrate nervous system: An old dog with new tricks. Neuron 69 855.
88. Caraballo-Miralles V, Cardona-Rossinyol A, Garcera A, Torres-Benito L, Soler RM, et al. (2013) Notch signaling pathway is activated in motoneurons of spinal muscular atrophy. Int J Mol Sci 14: 11424-11437.
89. Dencker L, Annerwall E, Busch C, Erikkson U (1990) Localization of specific retinoid-binding sites and expression of cellular retinoic-acid-binding protein (CRABP) in the early mouse embryo. Development 110: 343-352.
90. Perez-Castro AV, Toth-Rogler LE, Wei L, Nguyen-Huu MC (1989) Spatial and temporal pattern of expression of the cellular retinoic acid-binding protein and the cellular retinol-binding protein during mouse embryogenesis. Proc Natl Acad Sci U S A 86: 8813-8817.
91. Hosler BA, LaRosa GJ, Grippo JF, Gudas LJ (1989) Expression of REX-1, a gene containing zinc finger motifs, is rapidly reduced by retinoic acid in F9 teratocarcinoma cells. Mol Cell Biol 9: 5623-5629.
92. Appel B and Eisen JS (2003) Retinoids run rampant: multiple roles during spinal cord and motor neuron development. Neuron 40: 461-464.
93. Diez del Corral R, Olivera-Martinez I, Goriely A, Gale E, Maden M, et al. (2003) Opposing FGF and retinoid pathways control ventral nerve pattern, neuronal differentiation and segmentation during body axis formation. Neuron 40: 65-69.
94. Novitch BG, Wichterle H, Jessell TM, Sockanathan S (2003) A requirement for retinoic acid-mediated transcriptional activation in ventral neural patterning and motor neuron specification. Neuron 40: 81-95.
95. Liu H, Shafey D, Moores JN, Kothary R (2010) Neurodevelopmental consequences of Smn depletion in a mouse model of spinal muscular atrophy. J Neurosci Res 88: 111-122.
96. Ebert AD, Yu J, Rose Jr FF, Mattis VB, Lorson CL, et al. (2009) Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature 457: 277- 280.
97. Chang T, Zheng W, Tsark W, Bates S, Huang H, et al. (2011) Phenotypic rescue of induced pluripotent stem cell-derived motoneurons of a spinal muscular atrophy patient. Stem Cells (Dayt) 29: 2090-2093.
98. Corti S, Nizzardo M, Simone C, Falcone M, Nardini M, et al. (2012) Genetic correction of human induced pluripotent stem cells from patients with spinal muscular atrophy. Sci Transl Med 4: 165ra162.
99. Sareen D, Ebert AD, Heins BM, McGivern JV, Ornelas L, et al. (2012) Inhibition of apoptosis blocks human motor neuron cell death in a stem cell model of spinal muscular atrophy. PLoS ONE 7: e39113.
100. Le TT, Pham LT, Butchbach MER, Zhang HL, Monani UR, et al. (2005) SMND7, the major product of the centromeric survival motor neuron gene (SMN2), extends survival in mice with spinal muscular atrophy and associates with full-length SMN. Hum Mol Genet 14: 845-857.
101. Kariya S, Park GH, Maeno-Hikichi Y, Leykekhman O, Lutz C, et al. (2008) Reduced SMN protein impairs maturation of the neuromuscular junctions in mouse models of spinal muscular atrophy. Hum Mol Genet 17: 2552-2569.
102. Chang HCH, Dimlich DN, Yokokura T, Mukherjee A, Kankel MW, et al. (2008) Modeling spinal muscular atrophy in Drosophila. PLoS ONE 3: e3209.
103. Kong L, Wang X, Choe DW, Polley M, Burnett BG, et al. (2009) Impaired synaptic vesicle release and immaturity of neuromuscular junctions in spinal muscular atrophy mice. J Neurosci 29: 842-851.